Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empiric Cefixime and Azithromycin for Mucopurulent Cervicitis
NCT01072136Phase 3Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2010
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin, cefixime in cervicitis, sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2010; status: terminated.
02
Drugs
azithromycincefixime
03
Conditions
cervicitis
Beyond the preview
Go deeper on NCT01072136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01072136.